Searching recalls…
Searching…
Searching…
Home › Prescription medicine › Fresenius Kabi Issues Nationwide Recall of…
Check whether yours is affected, and ask your pharmacist or doctor before changing anything.
FOR IMMEDIATE RELEASE – August 10, 2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 mL vials to the user level. An internal investigation at the firm found the product to…
The Recall Registry rates this worth checking — we found nothing in the notice describing a specific injury. A recall covers only the versions, UPCs or date codes it names, so check those against yours.
Read the full announcement on FDA.gov using the link below — it lists the affected lots and what the company is offering.
Who to contact: Announced by Fresenius Kabi
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine